5 results
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
Pain, Agitation, and Delirium (PAD) in the ICU
Addressing the ICU Triad (PAD) can be accomplished through
will vary with clinical ... A dissociative drug ... non-OTC prolonging agent ... No pharmacologic ... #CriticalCare #
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
& Dry) is the treatment ... the determined cause ... #heartfailure #chf ... #criticalcare # ... icu #clinical #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... Weaknesses: High MIC ... Weaknesses: Therapeutic drug ... Weaknesses: Limited clinical ... Coccidioidomycosis #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
of antifungal agents ... tolerable • High MIC ... • Therapeutic drug ... tolerable • Limited clinical ... comparison #table #pharmacology